SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-069868
Filing Date
2024-08-15
Accepted
2024-08-15 19:38:56
Documents
2
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 2922
2 POWER OF ATTORNEY ea021158801ex24-1_biomotion.htm EX-24.1 6400
  Complete submission text file 0001213900-24-069868.txt   10740
Mailing Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177
Business Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177 212-572-6395
Biomotion Sciences (Issuer) CIK: 0002022416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5 NARCISSUS BOULEVARD RAMAT GAN L3 5258505
Business Address
Lushi Avner (Reporting) CIK: 0002033604 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42253 | Film No.: 241213836